0022
COM:NHWA-GROUP
江苏恩华药业股份有限公司
- Stock
Company Information
| msh id | COM:NHWA-GROUP |
| symbol | 2.26K |
| name | Jiangsu Nhwa Pharmaceutical Co., LTD |
| homepage url | https://www.nhwa-group.com |
| country | CN |
| sector | Healthcare |
| industry | Drug Manufacturers - Specialty & Generic |
| market | STOCKS |
| employee count | 5.39K |
| crunchbase url | - |
| linkedin url | - |
| founders | - |
Market Metrics
| market cap | 3.15B |
| enterprise value | - |
| stage | - |
| raised capital | - |
| valuation | - |
Web & Growth Metrics
| monthly webtraffic | - |
| monthly webtraffic growth | - |
| growth score 14 | - |
| growth score 28 | - |
| growth score 90 | - |
| growth score 365 | - |
LTM & NTM Metrics
| revenue ltm | - |
| gross profit ltm | - |
| ebitda ltm | - |
| net income ltm | - |
| revenue ntm | - |
| gross profit ntm | - |
| ebitda ntm | - |
| net income ntm | - |
Growth & Performance Metrics
| growth cost and expenses | 0.17 |
| growth cost of revenue | 0.43 |
| growth depreciation and amortization | 0.1 |
| growth ebitda | 0.07 |
| growth ebitda ratio | -0.07 |
| growth eps | - |
| growth eps diluted | - |
| growth general and administrative expenses | 0.17 |
| growth gross profit | 0.07 |
| growth gross profit ratio | -0.07 |
Operating Metrics
| cost and expenses | 539.58M |
| cost of revenue | 539.58M |
| depreciation and amortization | 24.2M |
| ebitda | 172.04M |
| ebitda ratio | 0.25 |
| eps | 0.14 |
| eps diluted | 0.14 |
| operating expenses | 337.73M |
| operating income | 147.84M |
| operating income ratio | 0.22 |
Balance Sheet Metrics
| accounts receivables | -27.51M |
| capital expenditure | -51.69M |
| cash at beginning of period | 211.78M |
| cash at end of period | 298.4M |
| inventory | 86.89M |
| working capital ttm | - |
Financial Metrics (2022-2026)
| 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|
| Revenue Metrics | |||||
| Revenue | - | - | - | - | - |
| Revenue Growth | - | - | - | - | - |
| Revenue Multiple | - | - | - | - | - |
| Profit Metrics | |||||
| Gross Profit | - | - | - | - | - |
| Gross Profit Growth | - | - | - | - | - |
| Gross Profit Multiple | - | - | - | - | - |
| EBITDA Metrics | |||||
| EBITDA | - | - | - | - | - |
| EBITDA Growth | - | - | - | - | - |
| EBITDA Multiple | - | - | - | - | - |
| Net Income Metrics | |||||
| Net Income | - | - | - | - | - |
| Net Income Growth | - | - | - | - | - |
| Net Income Multiple | - | - | - | - | - |